How AI is making clinical trials more accurate and affordable
February 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials
Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …
NICE plans to use broader range of data in guidance
February 5, 2020Research and Development NHS, NHS NICE, NICE
The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …
Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study
February 5, 2020Research and Development Bayer, Eylea, pharma
Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …
Final UK flight from Wuhan to bring home Britons from coronavirus epicenter
February 5, 2020Research and Development Wuhan Coronavirus, Wuhan Virus, china coronavirus, coronavirus
The last flight from Wuhan will arrive back in the UK on Sunday, bringing back British nationals fleeing from the …
Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine
February 5, 2020Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus
The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …
Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds
February 5, 2020Research and Development AIDS, HIV, STDs, STIs, UK, sexual health
The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …
New study casts doubt on effectiveness of psychotherapy treatments for military-related PTSD
February 4, 2020Manufacturing and Production PTSD, PTSD Iraq, PTSD Therapy, PTSD WAR, PTSD military
A recent review of clinical trials shows that first-line psychotherapies are limited in how effectively they treat veterans with PTSD.
Europe’s CHMP recommends Pfizer’s biosimilar of Roche’s MabThera
February 4, 2020Manufacturing and Production, Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar, pharma
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has revealed that it has awarded a positive opinion for …
Sanofi charged in birth defects case in France
February 4, 2020Manufacturing and Production Sanofi, Sanofi Birth Defects, Sanofi France
Sanofi has been charged with failure to adequately warn patients about their anti-epilepsy drug which has been linked to birth …
National Institutes of Health terminates HIV vaccine after it proves ineffective
February 4, 2020Manufacturing and Production HIV, pharma
A trial investigating the efficacy of a new HIV vaccine conducted by the National Institute of Allergy and Infectious Diseases …
China admits its coronavirus response had “shortcomings”
February 4, 2020Manufacturing and Production China, MERS, Sars, Wuhan, china coronavirus, coronavirus, wuihan coronavirus
In a rare move, China’s leadership has admitted “shortcomings” in the way it has handled the outbreak of the deadly …
Insider Interview: Reducing the risk of adverse cardiovascular events
February 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma
Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
Gilead’s experimental Ebola drug being tested in patients infected with coronavirus
February 3, 2020Sales and Marketing Coronavirus Wuhan, MERS, Sars, Wuhan, coronavirus, coronavirus China
China and the US are testing Gilead’s remdesivir in patients with the coronavirus, in the hopes of developing an effective …
BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell lung cancer
February 3, 2020Sales and Marketing BMS, Cancer, Europe, Yervoy, lung cancer, opdivo
Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …
More Britons evacuated from Wuhan as UK donates £20 million to speed up vaccine
February 3, 2020Sales and Marketing China virus, MERS, Sars, Wuhan Coronavirus, coronavirus, coronavirus China
More Britons have been flown back from Wuhan, the heart of the coronavirus outbreak, while the UK government has donated …
AbbVie’s Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic leukaemia
February 3, 2020Sales and Marketing AbbVie, CHMP, EMA, Venclyxto, pharma
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …
FDA approves first treatment for peanut allergy
February 3, 2020Sales and Marketing FDA, FDA Peanuts, peanut, peanut allergy, peanut medicine
The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …
AI firm Exscientia appoints COO and Head of Drug Discovery
January 31, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment
AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …
NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”
January 31, 2020Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma
NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …
Top Ten most popular articles on Pharmafile.com this week
January 31, 2020Medical Communications Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10
This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
